Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Tableting Lipid-based Formulations For Oral Drug Delivery: A Case Study With Silica Nanoparticle-lipid-mannitol Hybrid Microparticles.
K. Bremmell, A. Tan, Amanda Martin, C. Prestidge
Published 2013 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Silica-lipid-mannitol hybrid (SLMH) microparticles have been developed that were compressible into high quality tablets suitable for oral dosing and delivery of poorly soluble drugs. SLMH tablets enable high lipid-loading levels (>40%) and retain the immediate release, enhanced lipase digestion and drug solubilisation performance. Specifically, we report formulation optimisation of SLMH microparticles and tablets using coumarin 102 (log P = 4.09) as a model Biopharmaceutics Classification System class II drug. SLMH tablets were acceptable according to standard British Pharmacopoeia friability, hardness and disintegration tests; this is not the case for conventional dry emulsions. Furthermore, in vitro dissolution and pancreatic-lipase-induced lipolysis studies under simulated intestinal conditions have demonstrated enzymatic-digestion-mediated drug solubilisation. SLMH microparticles and tablets are suitable as liquid lipid containing solid dosage forms for enhancing and controlling oral absorption of poorly soluble drugs.
This paper references
Evaluation of the in‐vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products
L. Sek (2002)
Microemulsion formulation for enhanced absorption of poorly soluble drugs. II. In vivo study.
K. Kawakami (2002)
Effect of Certain Tablet Formulation Factors on Dissolution Rate of the Active Ingredient I11
G. Levy (1963)
Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System
Michael Levin (2001)
Formulation of a lyophilized dry emulsion tablet for the delivery of poorly soluble drugs
S. Corveleyn (1998)
Process characteristics and compaction of spray-dried emulsions containing a drug dissolved in lipid.
T. Hansen (2004)
Hybrid nanomaterials that mimic the food effect: controlling enzymatic digestion for enhanced oral drug absorption.
A. Tan (2012)
Material properties for making fast dissolving tablets by a compression method
S. Jeong (2008)
Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine.
C. H. Porter (2004)
Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems.
A. Tan (2010)
Drug Solubilization Behavior During in Vitro Digestion of Suspension Formulations of Poorly Water-Soluble Drugs in Triglyceride Lipids
A. Kaukonen (2004)
Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.
W. Charman (1997)
Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib.
N. Subramanian (2004)
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
C. H. Porter (2007)
Enhancing intestinal drug solubilisation using lipid-based delivery systems.
C. H. Porter (2008)
Design of Redispersible Dry Emulsion as an Advanced Dosage Form of Oily Drug (Vitamin E Nicotinate) by Spray-Drying Technique.
A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
B. Boyd (2007)
Use of a Dynamic in Vitro Lipolysis Model to Rationalize Oral Formulation Development for Poor Water Soluble Drugs: Correlation with in Vivo Data and the Relationship to Intra-Enterocyte Processes in Rats
A. Dahan (2006)
Factors affecting lipase digestibility of emulsified lipids using an in vitro digestion model: Proposal for a standardised pH-stat method
Y. Li (2011)
Silica-lipid hybrid microcapsules: influence of lipid and emulsifier type on in vitro performance.
Li Hui Lim (2011)
Solid-state nanoparticle coated emulsions for encapsulation and improving the chemical stability of all-trans-retinol.
Nasrin Ghouchi-Eskandar (2012)
Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
M. Grove (2006)
Influence of lipolysis on drug absorption from the gastro-intestinal tract
Karen J. MacGregor (1997)
Inhibition of lipase activities by basic polysaccharide Published, JLR Papers in Press, November 8, 2006.
T. Tsujita (2007)
Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers.
V. Naini (1998)
Silica-Lipid Hybrid (SLH) Versus Non-lipid Formulations for Optimising the Dose-Dependent Oral Absorption of Celecoxib
A. Tan (2011)
Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs.
A. Tan (2009)
A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption.
Ji-Yeon Hong (2006)
A dynamic in vitro lipolysis model. II: Evaluation of the model.
N. H. Zangenberg (2001)
Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
S. Simović (2009)
In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.
I. S. Ahmed (2007)
Susceptibility to Lipase-Mediated Digestion Reduces the Oral Bioavailability of Danazol After Administration as a Medium-Chain Lipid-Based Microemulsion Formulation
C. H. Porter (2004)
A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium.
N. H. Zangenberg (2001)
Enzymatic characterization of lipid-based drug delivery systems.
H. Ljusberg-Wahren (2005)
The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats.
A. Dahan (2007)
Technical optimisation of redispersible dry emulsions.
K. L. Christensen (2001)
Effect of shear mixing on in vitro drug release of capsule formulations containing lubricants.
K. Murthy (1977)
This paper is referenced by
Tablets of pre-liposomes govern in situ formation of liposomes: concept and potential of the novel drug delivery system.
Ž. Vanić (2014)
Porous Nanostructure, Lipid Composition, and Degree of Drug Supersaturation Modulate In Vitro Fenofibrate Solubilization in Silica-Lipid Hybrids
Ruba Almasri (2020)
Recent advances in self-emulsifying drug delivery systems (SEDDS).
B. Singh (2014)
Nanostructured Montmorillonite Clay for Controlling the Lipase-Mediated Digestion of Medium Chain Triglycerides.
Tahnee J. Dening (2016)
Using Hybrid Nanostructure to Improve the Performance of Oral Lipid Based Drug Delivery Systems
C. Prestidge (2013)
Innovative Strategies for Lipid-Based Drug Delivery
N. Sharma (2018)
Montmorillonite-lipid hybrid carriers for ionizable and neutral poorly water-soluble drugs: Formulation, characterization and in vitro lipolysis studies.
Tahnee J. Dening (2017)
Transforming Lipid-Based Oral Drug Delivery Systems into Solid Dosage Forms: An Overview of Solid Carriers, Physicochemical Properties, and Biopharmaceutical Performance
A. Tan (2013)
Improving Correlations Between Drug Solubilization and In Vitro Lipolysis by Monitoring the Phase Partitioning of Lipolytic Species for Lipid-Based Formulations.
Tahnee J. Dening (2019)
Oral lipid-based drug delivery: Inhibiting and eliminating digestion to improve absorption of poorly soluble drugs.
O. Feeney (2019)
Synergistic role of self-emulsifying lipids and nanostructured porous silica particles in optimizing the oral delivery of lovastatin.
Shasha Rao (2014)
Exploring Novel Strategies for Lipid-Based Drug Delivery
S. Kotta (2018)
Enhancing oral bioavailability of poorly soluble drugs with mesoporous silica based systems: opportunities and challenges
K. Bremmell (2019)
Formation of monodisperse hierarchical lipid particles utilizing microfluidic droplets in a nonequilibrium state.
M. Mizuno (2015)
Toward Directing Cell Fate: Carbon Nanotubes As Modulators of Extracellular and Transporters of Intracellular Cues
Qingsu Cheng (2013)
Impact of solidification on the performance of lipid-based colloidal carriers: oil-based versus self-emulsifying systems.
A. Alinaghi (2015)
First in man bioavailability and tolerability studies of a silica–lipid hybrid (Lipoceramic) formulation: a Phase I study with ibuprofen
A. Tan (2013)
50years of oral lipid-based formulations: Provenance, progress and future perspectives.
O. Feeney (2016)
Spray-drying of konjac glucomannan to produce microparticles for an application as antitubercular drug carriers
F. Guerreiro (2019)
Synergistic role of solid lipid and porous silica in improving the oral delivery of weakly basic poorly water soluble drugs
Rokhsana Yasmin (2017)
Perspective and potential of oral lipid-based delivery to optimize pharmacological therapies against cardiovascular diseases.
Shasha Rao (2014)
Controlling the enzymatic digestion of lipids using hybrid nanostructured materials.
A. Tan (2014)
Lyophilized silica lipid hybrid (SLH) carriers for poorly water-soluble drugs: physicochemical and in vitro pharmaceutical investigations.
Rokhsana Yasmin (2014)
Supersaturated Silica-Lipid Hybrid Oral Drug Delivery Systems: Balancing Drug Loading and In Vivo Performance
Hayley B Schultz (2019)
Furosemide Loaded Silica-Lipid Hybrid Microparticles: Formulation Development, in vitro and ex vivo Evaluation.
Swapna Sambaraj (2015)
years of oral lipid-based formulations : Provenance , progress and future perspectives ☆
O. Feeney (2016)
Porous Silica-Supported Solid Lipid Particles for Enhanced Solubilization of Poorly Soluble Drugs
Rokhsana Yasmin (2015)
Tripling the Bioavailability of Rosuvastatin Calcium Through Development and Optimization of an In-Situ Forming Nanovesicular System
Ibrahim Elsayed (2019)
Understanding the Mechanism of Enzyme-Induced Formation of Lyotropic Liquid Crystalline Nanoparticles.
L. Hong (2015)